Join us for a MedTalk with Berend Snijder, Professor at ETH Zurich and the Botnar Institute of Immune Engineering. Berend developed pharmacoscopy, a method that tests hundreds of drugs directly on living cells from a patient's own tumour, using automated microscopy and deep learning to find the right treatment within days. His work has already improved outcomes in blood cancers and recently revealed that a common antidepressant can kill glioblastoma cells. From his PhD at ETH to co-founding a biotech startup in Vienna, Berend's journey bridges computation, cancer biology, and real clinical impact. Don't miss the chance to discover how a microscope, a biopsy, and an algorithm are reshaping personalized medicine.
